BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 29978452)

  • 1. Stage I Non-Hodgkin Lymphoma: difference in survival outcome by primary extranodal site of involvement.
    Chihara D; Oki Y; Fanale MA; Westin JR; Nastoupil LJ; Neelapu S; Fayad L; Fowler NH; Cheah CY
    Br J Haematol; 2019 Apr; 185(2):334-338. PubMed ID: 29978452
    [No Abstract]   [Full Text] [Related]  

  • 2. Epidemiology, Tumor Characteristics, and Survival in Patients With Primary Pancreatic Lymphoma: A Large Population-based Study Using the SEER Database.
    Mukhija D; Nagpal SJS; Sohal DPS
    Am J Clin Oncol; 2019 May; 42(5):454-458. PubMed ID: 30950860
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Natural Killer/T-cell Neoplasms: Analysis of Incidence, Patient Characteristics, and Survival Outcomes in the United States.
    Kommalapati A; Tella SH; Ganti AK; Armitage JO
    Clin Lymphoma Myeloma Leuk; 2018 Jul; 18(7):475-479. PubMed ID: 29752210
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Survival outcomes of secondary cancers in patients with Waldenström macroglobulinemia: An analysis of the SEER database.
    Castillo JJ; Olszewski AJ; Kanan S; Meid K; Hunter ZR; Treon SP
    Am J Hematol; 2015 Aug; 90(8):696-701. PubMed ID: 25963924
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Persistent socioeconomic inequalities in cancer survival in the United States: 1973-2007 surveillance, epidemiology and end results (SEER) data for breast cancer and non-Hodgkin's lymphoma.
    Kato I; Booza J; Quarshie WO; Schwartz K
    J Registry Manag; 2012; 39(4):158-66. PubMed ID: 23493021
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiovascular mortality among patients with non-Hodgkin lymphoma: Differences according to lymphoma subtype.
    Abuamsha H; Kadri AN; Hernandez AV
    Hematol Oncol; 2019 Aug; 37(3):261-269. PubMed ID: 30916804
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differences in non-Hodgkin lymphoma survival between young adults and children.
    Tai E; Pollack LA; Townsend J; Li J; Steele CB; Richardson LC
    Arch Pediatr Adolesc Med; 2010 Mar; 164(3):218-24. PubMed ID: 20194253
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic Factors and Outcomes of Adult Lymphoblastic Lymphoma in the United States.
    El-Fattah MA
    Clin Lymphoma Myeloma Leuk; 2017 Aug; 17(8):498-505.e6. PubMed ID: 28647403
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cutaneous extranodal natural killer/T-cell lymphoma: a comparative clinicohistopathologic and survival outcome analysis of 45 cases according to the primary tumor site.
    Lee WJ; Jung JM; Won CH; Chang SE; Choi JH; Chan Moon K; Park CS; Huh J; Lee MW
    J Am Acad Dermatol; 2014 Jun; 70(6):1002-9. PubMed ID: 24629518
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A retrospective comparison of early stage primary extranodal with nodal non-Hodgkin lymphoma patients: A single center experience.
    Yazilitas D; Ozdemir N; Hocazade C; Bozkaya Y; Yazici O; Sendur MA; Zengin N
    J BUON; 2015; 20(6):1526-33. PubMed ID: 26854450
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Primary gastrointestinal non-Hodgkin lymphoma in adults: clinicopathologic and survival characteristics.
    Radić-Kristo D; Planinc-Peraica A; Ostojić S; Vrhovac R; Kardum-Skelin I; Jaksić B
    Coll Antropol; 2010 Jun; 34(2):413-7. PubMed ID: 20698111
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Extranodal non-Hodgkin's lymphomas--a retrospective review of clinico-pathologic features and outcomes in comparison with nodal non-Hodgkin's lymphomas.
    Lal A; Bhurgri Y; Vaziri I; Rizvi NB; Sadaf A; Sartajuddin S; Islam M; Kumar P; Adil S; Kakepoto GN; Masood N; Khurshed M; Alidina A
    Asian Pac J Cancer Prev; 2008; 9(3):453-8. PubMed ID: 19004134
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Reference data on survival of cancer patients in 17 European countries].
    Sant M
    Epidemiol Prev; 2000; 24(1):44-5. PubMed ID: 10748550
    [No Abstract]   [Full Text] [Related]  

  • 14. Disparities in conditional net survival among non-Hodgkin lymphoma survivors: a population-based analysis.
    Migdady Y; Salhab M; Dang NH; Markham MJ; Olszewski AJ
    Leuk Lymphoma; 2016; 57(3):676-84. PubMed ID: 26428541
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A highly curable lymphoma occurs preferentially in the proximal tibia of young patients.
    Subik MK; Herr M; Hutchison RE; Kelly J; Tyler W; Merzianu M; Burack WR
    Mod Pathol; 2014 Nov; 27(11):1430-1437. PubMed ID: 24743213
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Primary extranodal non-Hodgkin lymphoma of the oral cavity. An analysis of 34 cases.
    Wolvius EB; van der Valk P; van der Wal JE; van Diest PJ; Huijgens PC; van der Waal I; Snow GB
    Eur J Cancer B Oral Oncol; 1994; 30B(2):121-5. PubMed ID: 8032301
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Disparate survival and risk of secondary non-Hodgkin lymphoma in histologic subtypes of Hodgkin lymphoma: a population-based study.
    Ali S; Olszewski AJ
    Leuk Lymphoma; 2014 Jul; 55(7):1570-7. PubMed ID: 24067135
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Non-melanoma skin cancer may be a marker of poor prognosis in patients with non-Hodgkin's lymphoma.
    Hjalgrim H; Frisch M; Storm HH; Glimelius B; Pedersen JB; Melbye M
    Int J Cancer; 2000 Mar; 85(5):639-42. PubMed ID: 10699942
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Treatment outcome in primary testicular non-Hodgkin lymphoma].
    Iványi JL; Marton E; Plander M; Engert ZV; Tóth C
    Orv Hetil; 2013 Oct; 154(42):1666-73. PubMed ID: 24121219
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characteristics, survival and incidence rates and trends of primary cardiac malignancies in the United States.
    Saad AM; Abushouk AI; Al-Husseini MJ; Salahia S; Alrefai A; Afifi AM; Abdel-Daim MM
    Cardiovasc Pathol; 2018; 33():27-31. PubMed ID: 29414429
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.